A comprehensive analysis of nearly 50,000 assessments has revealed significant deficiencies in vision and hearing care provision for frail older adults in New Zealand,
The UNSW School of Optometry and Vision Science has set an ambitious goal: to raise over AU$2 million by May 2026 to fund its
Afqlir (aflibercept), a 2 mg pre-filled syringe for intravitreal injection developed by Sandoz, is now available in Australia.
Data from SeeWay has highlighted the critical importance of early, lifestyle-focussed support for patients adjusting to vision loss.
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
